OKYO Pharma Announces Chairman and Founder Acquires Shares

Summary by AI BETAClose X

OKYO Pharma Limited announced that Panetta Partners Limited, an entity beneficially owned by Executive Chairman Gabriele Cerrone, acquired 27,051 ordinary shares on NASDAQ, increasing his total holding to 10,491,746 shares. This news comes as the company is developing urcosimod, a novel drug candidate for neuropathic corneal pain and dry eye disease, with a completed Phase 2 trial for neuropathic corneal pain and a recently concluded Phase 2 trial for dry eye disease showing statistical significance in multiple endpoints.

Disclaimer*

UK 100

Latest directors dealings